CDEK
← All organizations

Amryt Research Limited

For profitWebsite ↗

Also known as: AMRYT | Amryt Pharma | Amryt Pharmaceuticals DAC

Phase 1Phase 2Phase 3Phase 4

First clinical trial

Mar 29, 2017

First marketed drug

Dec 21, 2012

Last known activity

Oct 14, 2024

Acquired by Chiesi on Jan 9, 2023

Timeline

2010s

  1. Jun 1, 2012

    Amryt Research Limited— Founded

  2. Dec 21, 2012

    lomitapide— Marketing Organization

  3. Dec 21, 2012

    lomitapide— NDA Secondary Org

  4. Feb 22, 2016

    Birken AG— Acquired

  5. May 13, 2016

    Sompharmaceuticals— Acquired

  6. May 21, 2019

    Novelion Therapeutics— Acquired

2020s

  1. May 5, 2021

    Chiasma, Inc.— Acquired

  2. Jan 9, 2023

    Chiesi— Acquired By

Drugs by trial phase (38 distinct, 68 trials)

Phase 4 (0 own, 3 via acquisition)

Phase 1 (0 own, 2 via acquisition)

Indications

Studied for

Marketed drugs (3)

Subsidiaries (4 direct, 4 total across the full acquisition tree)

Recent trials (7)

Details

Founded
Dublin, IE Jun 1, 2012
Last known activity
Oct 14, 2024